197 related articles for article (PubMed ID: 10023101)
1. GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal contraception.
Wildemeersch D; Batár I; Webb A; Gbolade BA; Delbarge W; Temmerman M; Dhont M; Guillebaud J
Br J Fam Plann; 1999 Jan; 24(4):149-59. PubMed ID: 10023101
[TBL] [Abstract][Full Text] [Related]
2. Acceptability and clinical performance of a copper-containing frameless IUCD in Hong Kong.
Wong CY; Ng WL; Lo ST; Fan YS
Contraception; 2005 Jan; 71(1):51-4. PubMed ID: 15639073
[TBL] [Abstract][Full Text] [Related]
3. The GyneFix implant systems for interval, postabortal and postpartum contraception: a significant advance in long-term reversible contraception. International Study Group on Intrauterine Drug Delivery.
Van Kets H; Van der Pas H; Thiery M; Wildemeersch D; Vrijens M; Van Trappen Y; Temmerman M; DePypere H; Delbarge W; Dhont M; Defoort P; Schacht EH; Bàtàr I; Barri P; Martinez F; Iglesias Cortit LH; Creatsas G; Shangchun W; Xiaoming C; Zuan-chong F; Yu-ming W; Andrade A; Reinprayoon D; Pizarro E
Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):1-13. PubMed ID: 9678104
[TBL] [Abstract][Full Text] [Related]
4. Preventing abortion and repeat abortion with the Gynefix intrauterine implant system--preliminary results.
Batar I; Wildemeersch D; Vrijens M; Delbarge W; Temmerman M; Gbolade BA
Adv Contracept; 1998 Jun; 14(2):91-6. PubMed ID: 9820927
[TBL] [Abstract][Full Text] [Related]
5. New frameless and framed intrauterine devices and systems - an overview.
Wildemeersch D
Contraception; 2007 Jun; 75(6 Suppl):S82-92. PubMed ID: 17531623
[TBL] [Abstract][Full Text] [Related]
6. [Intrauterine copper contraceptive implants].
Van Kets H; Thiery M; Wildemeersch D; Delbarge W; Vrijens M; Van der Pas H; Depypere H; Parewijck W; Temmerman M; Van Trappen Y; Van den Ostende G
Contracept Fertil Sex; 1996 Dec; 24(12):908-11. PubMed ID: 9026279
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
8. Immediate post-abortal insertion of the frameless GyneFix IUD: initial experience in China.
Cao X; Zhang W; Gao Y; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; van Kets H; Wildemeersch D
Br J Fam Plann; 2000 Apr; 26(2):85-8. PubMed ID: 10773600
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
10. Interval and postabortal contraception with the frameless GyneFix.
Wildemeersch D; Batár I
Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):269-73. PubMed ID: 9678085
[TBL] [Abstract][Full Text] [Related]
11. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system.
Cao X; Zhang W; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; Wildemeersch D
Contraception; 2004 Mar; 69(3):207-11. PubMed ID: 14969668
[TBL] [Abstract][Full Text] [Related]
12. Post coital contraception.
Haspels AA; Van Santen MR
J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
[TBL] [Abstract][Full Text] [Related]
13. The frameless GyneFix intrauterine implant: a major improvement in efficacy, expulsion and tolerance.
van Kets H; Vrijens M; Van Trappen Y; Delbarge W; van der Pas H; Temmerman M; Depypere H; Batar I; Barri P; Martinez F
Adv Contracept; 1995 Jun; 11(2):131-42. PubMed ID: 7491854
[TBL] [Abstract][Full Text] [Related]
14. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system.
Delbarge W; Bátár I; Bafort M; Bonnivert J; Colmant C; Dhont M; Fonzé V; Gevers R; Janssens D; Lavalley P; Salmin E; Degueldre M; Vrijens M; Van Kets H; Wildemeersch D
Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):24-30. PubMed ID: 12041861
[TBL] [Abstract][Full Text] [Related]
15. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
[TBL] [Abstract][Full Text] [Related]
16. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
17. The 'frameless' intrauterine system for long-term, reversible contraception: a review of 15 years of clinical experience.
Wildemeersch D; Batár I; Affandi B; Andrade A; Shangchun W; Jing H; Xiaoming C
J Obstet Gynaecol Res; 2003 Jun; 29(3):164-73. PubMed ID: 12841701
[TBL] [Abstract][Full Text] [Related]
18. Cochrane systematic reviews of IUD trials: lessons learned.
Grimes DA; Lopez LM; Manion C; Schulz KF
Contraception; 2007 Jun; 75(6 Suppl):S55-9. PubMed ID: 17531618
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine devices and adolescents.
Gold MA; Johnson LM
Curr Opin Obstet Gynecol; 2008 Oct; 20(5):464-9. PubMed ID: 18797269
[TBL] [Abstract][Full Text] [Related]
20. Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices.
Wildemeersch D; Pett A; Jandi S; Hasskamp T; Rowe P; Vrijens M
Int J Womens Health; 2013; 5():215-25. PubMed ID: 23658502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
